Is Tonix Pharmaceuticals Holding Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: TNXP) stock is to Strong Buy TNXP stock.
Out of 1 analyst, 1 (100%) are recommending TNXP as a Strong Buy, 0 (0%) are recommending TNXP as a Buy, 0 (0%) are recommending TNXP as a Hold, 0 (0%) are recommending TNXP as a Sell, and 0 (0%) are recommending TNXP as a Strong Sell.
What is TNXP's forecast return on equity (ROE) for 2023-2024?
(NASDAQ: TNXP) forecast ROE is -32%, which is considered weak.
What is TNXP's Price Target?
According to 1 Wall Street analyst that have issued a 1 year TNXP price target, the average TNXP price target is $6.50, with the highest TNXP stock price forecast at $6.50 and the lowest TNXP stock price forecast at $6.50.
The Wall Street analyst predicted that Tonix Pharmaceuticals Holding's share price could reach $6.50 by Jan 12, 2024. The average Tonix Pharmaceuticals Holding stock price prediction forecasts a potential upside of 289.22% from the current TNXP share price of $1.67.
What is TNXP's forecast return on assets (ROA) for 2023-2024?
(NASDAQ: TNXP) forecast ROA is -29.56%, which is lower than the forecast US Biotechnology industry average of -0.57%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.